Emerging Infectious Disease ISSN: 1080-6059

Risk to Human Health from a Plethora of Simian Immunodeficiency Viruses in Primate Bushmeat

Martine Peeters*

, Valerie Courgnaud*, Bernadette Abela†, Philippe Auzel†‡, Xavier Pourrut*, Frederic Bibollet-Ruche§, Severin Loul†, Florian Liegeois*, Cristelle Butel*, Denis Koulagna¶, Eitel Mpoudi-Ngole†, George M. Shaw§, Beatrice H. Hahn§, and Eric Delaporte*

Author affiliations: *Institut de Recherche pour le Développement (IRD), Montpellier, France; †Projet Prevention du Sida au Cameroun (PRESICA), Yaounde, Cameroon; ‡Faculté Universitaire des Sciences Agronomiques de Gembloux, Gembloux, Belgium; §University of Alabama at Birmingham, Birmingham, Alabama, USA; ¶Ministry of Environment and Forestry, Yaounde, Cameroon;

Main Article

Figure 1

Detection of HIV-1/HIV-2 cross-reactive antibodies in sera from 11 primate species by using a line immunoassay (INNO-LIA HIV Confirmation, Innogenetics, Ghent, Belgium). Varying patterns of reactivity to HIV peptides and proteins (HIV-1 gp120, gp41, p31, p24, and p17; HIV-2 gp130, and gp36) are shown. Samples from which Simian immunodeficiency virus (SIV) sequences were subsequently amplified by polymerase chain reaction are color-coded as in Figure 2. Plasma samples from HIV-1/HIV-2-negative and -positive persons are shown as controls on the left. The 3+, 1+ and +/- bands at the top of all test strips control for sample addition (presence of plasma immunoglobulin) and test performance (binding of secondary antibody).

Figure 1. Detection of HIV-1/HIV-2 cross-reactive antibodies in sera from 11 primate species by using a line immunoassay (INNO-LIA HIV Confirmation, Innogenetics, Ghent, Belgium). Varying patterns of reactivity to HIV peptides and proteins (HIV-1 gp120, gp41, p31, p24, and p17; HIV-2 gp130, and gp36) are shown. Samples from which Simian immunodeficiency virus (SIV) sequences were subsequently amplified by polymerase chain reaction are color-coded as in Figure 2. Plasma samples from HIV-1/HIV-2-negative and -positive persons are shown as controls on the left. The 3+, 1+ and +/- bands at the top of all test strips control for sample addition (presence of plasma immunoglobulin) and test performance (binding of secondary antibody).

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.